Severe pulmonary adverse effects in lymphoma patients treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) regimen plus rituximab
Kyu Hyoung Lim, Ho Il Yoon, Young Ae Kang, Keun Wook Lee, Jee Hyun Kim, Soo Mee Bang, Jae Ho Lee, Choon Taek Lee, Jong Seok Lee
Dive into the research topics of 'Severe pulmonary adverse effects in lymphoma patients treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) regimen plus rituximab'. Together they form a unique fingerprint.